Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.

AIDS research and human retroviruses - 1 Apr 2004

Richard Nathalie, Juntilla Marisa, Abraha Awet, Demers Korey, Paxinos Ellen, Galovich Justin, Petropoulos Christo, Whalen Christopher C, Kyeyune Fred, Atwine Diana, Kityo Cissy, Mugyenyi Peter, Arts Eric J

Abstract excerpt

This study examined the emergence and prevalence of drug-resistant mutations in reverse transcriptase and protease coding regions in human immunodeficiency virus type 1 (HIV-1)-infected Ugandans treated with antiretroviral drugs (ARV). Genotypic resistance testing was performed on 50 and 16 participants who were enrolled in a cross-sectional and longitudinal observational cohort, respectively. The majority of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Longitudinal Studies

Share to Proviruses

Share to Uganda

Share to Viremia

Source

Identifiers

PMID: 15157354
DOI: 10.1089/088922204323048104

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.PMID 15157354Read ↗

HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic.Semantic proximity Read ↗

Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.Semantic proximity Read ↗

Resistance to antiretroviral therapy among patients in Uganda.Semantic proximity Read ↗

Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda.Semantic proximity Read ↗

Low drug resistance levels among drug-naive individuals with recent HIV type 1 infection in a rural clinical cohort in southwestern Uganda.Semantic proximity Read ↗

Population dynamics of HIV drug resistance during treatment scale-up in Uganda: a population-based longitudinal studySemantic proximity Read ↗

Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.Semantic proximity Read ↗

Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy.Semantic proximity Read ↗

Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period.Semantic proximity Read ↗

From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults.Semantic proximity Read ↗

Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.Semantic proximity Read ↗

High frequency of HIV-1 drug resistance among individuals with persistent low-level viremia during first-line antiretroviral therapy in Uganda.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.